Utility of BCL2, PD1, and CD25 immunohistochemical expression in the diagnosis of t-cell lymphomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 22, Issue 2, 2014, Pages 99-104

  O'Malley, Dennis P ^a   Chizhevsky, Vladislav ^a   Grimm, Kate E ^a   Hii, Anselm ^a   Weiss, Lawrence M ^a  

^a Clarient Inc   (United States)

Author keywords

anaplastic large cell lymphoma; angioimmunoblastic T cell lymphoma; BCL 2; CD25; PD 1; peripheral T cell lymphoma; T cell lymphoma

Indexed keywords

DENILEUKIN DIFTITOX; DIPHTHERIA TOXIN; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 2;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

DIAGNOSIS, DIFFERENTIAL; DIPHTHERIA TOXIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896739630     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31828ef1f7     Document Type: Article

References (32)

1. Foss FM, Zinzani PL, Vose JM, et al. Peripheral T-cell lymphoma. Blood. 2011;117:6756-6767.
2. Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117: 3402-3408.
3. Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002;13:140-149.
4. Placzek WJ, Wei J, Kitada S, et al. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis. 2010;1:e40.
5. Patel MP, Masood A, Patel PS, et al. Targeting the Bcl-2. Curr Opin Oncol. 2009;21:516-523.
6. Freedman A. Follicular lymphoma: 2012 update on diagnosis and management. Am J Hematol. 2012;87:988-995.
7. Mahmoud HM, El-Sakhawy YN. Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma. Hematol Rep. 2011;3:e26.
8. Weiss LM. Peripheral T cell lymphoma, unspecified. Lymph Nodes. Cambridge, UK: Cambridge University Press; 2008:190-196.
9. Gaulard P, de Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol. 2011;28:202-213.
10. Huang Y, Moreau A, Dupuis J, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33:682-690.
11. Manoukian G, Hagemeister F. Denileukin diftitox: a novel immunotoxin. Expert Opin Biol Ther. 2009;9:1445-1451.
12. Jones D, Ibrahim S, Patel K, et al. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res. 2004;10:5587-5594.
13. Akagi T, Kondo E, Yoshino T. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues. Leuk Lymphoma. 1994;13:81-87.
14. + helper T cells. A model for the long-term survival of memory cells. J Immunol. 1996;156:1764-1771.
15. + T cells. J Immunol. 2000;164:3950-3954.
16. + anaplastic large-cell lymphoma. Biomed Environ Sci. 2011;24:630-641.
17. Benner MF, Jansen PM, Meijer CJ, et al. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol. 2009;161:121-127.
18. Yasuda H, Sugimoto K, Imai H, et al. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK/T-cell lymphoma. Eur J Haematol. 2009;82:39-45.
19. Schwartz EJ, Molina-Kirsch H, Zhao S, et al. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol. 2008;130:343-351.
20. + lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study. Br J Dermatol. 2007; 157:41-48.
21. Bossard C, Belhadj K, Reyes F, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2007;109:2183-2189.
22. Jung JT, Kim DH, Kwak EK, et al. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas. Ann Hematol. 2006;85:575-581.
23. Drakos E, Rassidakis GZ, Lai R, et al. Caspase-3 activation in systemic anaplastic large-cell lymphoma. Mod Pathol. 2004;17:109-116.
24. Rassidakis GZ, Jones D, Lai R, et al. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol. 2003;200:240-248.
25. Rassidakis GZ, Jones D, Thomaides A, et al. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002;118: 328-334.
26. Ten Berge RL, Meijer CJ, Dukers DF, et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood. 2002;99:4540-4546.
27. + NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol. 2000;113:201-211.
28. Kagami Y, Suzuki R, Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999;23:1184-1200.
29. Quintanilla-Martinez L, Franklin JL, Guerrero I, et al. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol. 1999; 30:849-855.
30. Lorenzen J, Liu WP, Gi GD, et al. Nasal T/NK cell lymphoma: a clinico pathologic study of 30 west Chinese patients with special reference to proliferation and apoptosis. Leuk Lymphoma. 1996; 23:593-602.
31. Dorfman DM, Shahsafaei A. CD200 (OX-2 membrane glycopro-tein) is expressed by follicular T helper cells and in angioimmuno-blastic T-cell lymphoma. Am J Surg Pathol. 2011;35:76-83.
32. Dupuis J, Boye K, Martin N, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol. 2006;30:490-494.